Belgium· BE-AMP-SAM425153-00
Fycompa 4 mg
A perampanel product containing perampanel, registered in Belgium by Eisai. The same ATC class is registered in 18 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Perampanel is registered in 18 of 19 countries.
Countries holding a registration under ATC N03AX22 (perampanel), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Perampanel · ATC N03AX22
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of perampanel costs, country by country.
Normalised to the WHO defined daily dose (8 mg), the median price runs from $2.78 in France to $12.43 in Switzerland — a ×4.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Perampanel · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$12.43
- IT Italy$4.65
- ES Spain$3.99
- FR France$2.78
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Perampanel
- Manufacturer
- Eisai
- Country
- Belgium (BE)
- ATC code
- N03AX22
- ATC class
- Perampanel
- Defined daily dose
- 8 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 8
4 priced- be_apb3115193EUR 106.63
- be_apb4829396EUR 106.63
- be_apb4969275EUR 106.63
- be_apb4981395EUR 106.63
- be_apb7708019
- be_apb7741820
- be_apb7747108
- be_apb7748197
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for perampanel.
Graded by severity as the source publishes them — 77 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Perampanel · interactions on record
80 records
- 77 moderate
- 3 minor
Most severe, free to view
- MetoclopramideA03FA01moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Perampanel in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFYCOMPAEisai GmbH, Frankfurt am Main
- SpainAMPENAIA 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGDesitin Arzneimittel Gmbh
- United StatesPerampanelNovadoz Pharmaceuticals LLC
- ItalyFYCOMPAEISAI GMBH
- FinlandFycompaOrifarm Oy
- SwedenFycompa 4 mg Filmdragerad tablettEisai GmbH
- PolandFycompaEisai GmbH
- NetherlandsFycompa 4 mg filmomhulde tablettenEisai GmbH
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Fypalan, Perampanel Ratiopharm
- Cyprus · Fylepsia
- Czechia · Fypalan, Perampanel Orion
- Germany · Fylepsia, Fypalan
- Denmark · Perampanel Orion, Perampanel Vivanta
- Spain · Perampanel Cinfa, Perampanel Combix
- Finland · Perampanel Orion
- France · Perampanel Teva
- United Kingdom (Northern Ireland) · Perampanel Aspire, Perampanel G.L. Pharma
- Greece · Fylepsia, Perampanel Win Medica
- Iceland · Fycompa
- Italy · Fypalan, Perampanel Doc
- Liechtenstein · Fycompa
- Netherlands · Fypalan, Perampanel Sandoz
- Norway · Fycompa, Perampanel Orion
- Poland · Fypalan, Perampanel Orion
- Portugal · Perampanel Teva
- Sweden · Perampanel Orion, Perampanel Vivanta
- Slovakia · Fypalan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bef74229-bdb3-445c-899e-528363d91c3a GET /v1/drugs/bef74229-bdb3-445c-899e-528363d91c3a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Fycompa 4 mg",
"name_fr": "Fycompa 4 mg",
"name_nl": "Fycompa 4 mg",
"amp_code": "SAM425153-00",
"strengths": [
"4.0000",
"4.0000"
],
"pack_count": 7,
"substances": [
"Perampanel",
"Lactose Monohydrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Perampanel",
"authorisation_numbers": [
"EU/1/12/776/003",
"EU/1/12/776/002",
"EU/1/12/776/004",
"EU/1/12/776/019"
]
}See everything about perampanel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.